Nantahala Capital Management »

Unicycive Therapeutics shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Unicycive Therapeutics (UNCY) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Unicycive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Unicycive Therapeutics held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unicycive Therapeutics by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $4.1M 939k 4.36
2025-06-30 $4.6M 939k 4.86

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Edwards Lifesciences Put Option (EW)
Hilton Grand Vacations (HGV)
Establishment Labs Holdings Ord (ESTA)
Peloton Interactive Cl A Com (PTON)
Spdr Series Trust S&p Biotech Put Option (XBI)
Herbalife Com Shs (HLF)
Soleno Therapeutics (SLNO)
Ban (TBBK)
Uniqure Nv SHS (QURE)
Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA)
Viatris Call Option (VTRS)
Abivax Sa Sponsored Ads (ABVX)
Xtant Med Hldgs Com New (XTNT)
Fulcrum Therapeutics (FULC)

View all positions for Nantahala Capital Management

Top funds holding Unicycive Therapeutics

Vivo Capital
Octagon Capital Advisors
Nantahala Capital Management
Dr. Jeffrey R. Jay, M.D.
Vanguard Group
Logos Global Management
Geode Capital Management
Squarepoint Ops
Longwood Capital Partners
State Street Corporation
Goldman Sachs Group
Citadel Advisors
XTX Topco
BlackRock
Northern Trust

View all funds holding Unicycive Therapeutics